George R Thompson
University of California, Davis
H-index: 59
North America-United States
Top articles of George R Thompson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The Burden of Invasive Fungal Disease Following CAR T-cell Therapy and Strategies for Prevention | Jessica S Little Eleftheria Kampouri Daniel Z Friedman Todd McCarty George R Thompson III | 2024/3/13 | |
Epidemiological trends and clinical outcomes of cryptococcosis in a medically insured population in the United States: a claims-based analysis from 2017 to 2019 | Therapeutic Advances in Infectious Disease | Daniel B Chastain Qian Zhang Xianyan Chen Henry N Young Carlos Franco-Paredes | 2024/4 |
P30 Efficacy and safety of rezafungin in critically ill patients with candidaemia and/or IC: Outcomes of patients treated in the ICU from an integrated analysis of Phase 2 and … | JAC-Antimicrobial Resistance | PM Honore M Kollef GR Thompson A Soriano OA Cornely | 2024/1 |
Safety of Fluconazole in Kidney Transplant Recipients for Prevention of Coccidioidomycosis | Medical Mycology | Laya Reddy George R Thompson III Natascha Tuznik Tina A Zolfaghari Joy Vongspanich Dray | 2024/2/29 |
Reply to Williams et al | Clinical Infectious Diseases | Francis Verdial Matthew Bartek E Patchen Dellinger | 2018/10/15 |
403 Epithelial hypoxia maintains colonization resistance against Candida albicans | Journal of Clinical and Translational Science | Derek J Bays Hannah P Savage Connor Tiffany Mariela AF Gonzalez Eli J Bejarano | 2024/4 |
Utility of Microbial Cell Free DNA Next-Generation Sequencing for Diagnosis and Management of Infectious Diseases | Diagnostic Microbiology and Infectious Disease | Riley Aiden-Croix Thompson Monica A Donnelley Kate Trigg Sili Fan Machelle D Wilson | 2024/4/26 |
P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and … | JAC-Antimicrobial Resistance | Oliver A Cornely George R Thompson Alex Soriano Bart-Jan Kullberg Marin Kollef | 2024/1 |
Challenges to implementing a vaccine for coccidioidomycosis | Open Forum Infectious Diseases | Bridget M Barker George R Thompson III Neil M Ampel | 2024/2/19 |
Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis | Mycoses | Luke Kim Carolina Ferraz Michaele Francesco Corbisiero Sarah Gorvetzian Carlos Franco‐Paredes | 2024/3 |
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis | Antimicrobial Agents and Chemotherapy | Jeffrey B Locke Chris M Pillar Mariana Castanheira Cecilia G Carvalhaes David Andes | 2024/3/25 |
Infectious Diseases in a Changing Climate | JAMA | Matthew C Phillips Regina C LaRocque George R Thompson | 2024/4/16 |
The dog as a sentinel and animal model for coccidioidomycosis | Adam J Ferguson George R Thompson David Bruyette Jane E Sykes | 2024/1 | |
Hypoxemic Respiratory Failure and Coccidioidomycosis-Associated Acute Respiratory Distress Syndrome | Open Forum Infectious Diseases | Arash Heidari Simmer Kaur Skyler J Pearson Augustine Munoz Harleen Sandhu | 2024/2 |
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies | Jo-Anne H Young David R Andes Monica I Ardura Antonio Arrieta Eric J Bow | 2024/3 | |
Invasive candidiasis | Peter G Pappas Michail S Lionakis Maiken Cavling Arendrup Luis Ostrosky-Zeichner Bart Jan Kullberg | 2018/5/11 | |
Epidemiological, clinical, and genomic landscape of coccidioidomycosis in northeastern Brazil | Nature Communications | Kelsen Dantas Eulálio Daniel R Kollath Liline Maria Soares Martins Antonio de Deus Filho Maria do Amparo Salmito Cavalcanti | 2024/4/12 |
Comparison of coccidioidal complement fixation and quantitative immunodiffusion serology at a reference laboratory | Medical Mycology | Allen W Bryan Jr Jane Sykes Kelly Crucillo Kaihua Zhang Derek J Bays | 2024/1 |
Clinical testing guidance for histoplasmosis in patients with community-acquired pneumonia for primary and urgent care providers: Commentary on Enzyme Immunoassay Histoplasma … | Clinical Infectious Diseases | Dallas J Smith George R Thompson III John W Baddley Peter G Pappas Lisa A Tushla | 2024/1/3 |
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial | Open forum infectious diseases | Andrej Spec George R Thompson Marisa H Miceli Justin Hayes Laurie Proia | 2024/3 |
Co-Authors
